Botanicals for regulating heart rhythms

Alternative and Complementary Therapies

Volumn 9, Issue 3, 2003, Pages 125-129

  Yarnell, Eric ^a,b   Abascal, Kathy ^a,b  

^a Botanical Medicine Academy ^*

^b Botanical Medicine Academy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CONVALLARIA MAJALIS EXTRACT; CRATAEGUS LAEVIGATA EXTRACT; ENCAINIDE; FLECAINIDE; HYLOCEREUS UNDATUS EXTRACT; KAVA; LEONURUS CARDIACA EXTRACT; PASSIFLORA INCARNATA EXTRACT; PLANT EXTRACT; RAUWOLFIA EXTRACT; SCUTELLARIA LATERIFLORA EXTRACT; SCUTELLARIAE RADIX; SEDATIVE AGENT; SELENICEREUS GRANDIFLORUS EXTRACT; UNCLASSIFIED DRUG; VALERIAN; ZIZYPHUS JUJUBA EXTRACT; ZIZYPHUS SATIVA EXTRACT;

ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CRATAEGUS; CYTISUS; DEPRESSION; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CROSS REACTIVITY; DRUG OVERDOSE; DRUG POTENCY; DRUG SAFETY; DRUG UTILIZATION; HEART ARRHYTHMIA; HEART RHYTHM; HUMAN; HYPERTENSION; HYPOKALEMIA; JUJUBE; LILY; MYOTONIA; NAUSEA; NONHUMAN; NOSE CONGESTION; PASSIFLORA INCARNATA; PASSION FRUIT; PATIENT MONITORING; PHYTOTHERAPY; PREGNANCY COMPLICATION; RAUWOLFIA; SCUTELLARIA; SCUTELLARIA LATERIFLORA; SEDATION; SIDE EFFECT; TREATMENT INDICATION; VALERIANA; VALERIANA OFFICINALIS; VALERIANA SITCHENSIS;

EID: 0038070474     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/107628003322017350     Document Type: Article

References (28)

1. Weiss RF. Herbal Medicine. Beaconsfield, UK: Beaconsfield Publishers, 1988:186.
2. Felter HW. Eclectic Materia Medica, Pharmacology and Therapeutics. Sandy, OR: Eclectic Medical Publications, 1922 [reprinted 1998].
3. Denham A, McIntyre M, Whitehouse J. Kava - the unfolding story: Report of a work-in-progress. J Altern Complement Med 2002;8:237-263;
4. with special Appendix 1: Whitton P, Whitehouse J, Evans C. Response to reported hepatotoxicity of high lactone extractions of Piper mythysticum Forst. (kava)].
5. Hoffmann D. The Complete Illustrated Herbal. New York: Barnes & Noble, 1996:142.
6. Weiss RF. Herbal Medicine. Beaconsfield, UK: Beaconsfield Publishers, 1988:150.
7. Thies PW. Spartium and sparteine: Its antiarrhythmic action [in German]. Pharmazie unserer Zeit 1986;6:172-176.
8. Northover BJ. Effect of pre-treating rat atria with potassium channel blocking drugs on the electrical and mechanical responses to phenylephrine. Biochem Pharmacol 1994;47:2163-169.
9. Puglsey MK, Saint DA, Hayes E, et al. The cardiac electrophysiological effects of sparteine and its analogue BRB-I-28 in the rat. Eur J Pharmacol 1995;294:319-327.
10. Honerjager P, Loibl E, Steidl I, et al. Negative inotropic effects of tetrodotoxin and seven class I antiarrhythmic drugs in relation to sodium channel blockade. Naunyn Schmiedebergs Arch Pharmacol 1986;332:184-195.
11. United States Food and Drug Administration. Online document at: www.fda.gov/ohrms/dockets/98fr/100898b.txt
12. Bank on Data Automated on Drugs. Online document at www.biam2.org Accessed March 30, 2003.
13. Hoffmann D. The Complete Illustrated Herbal. New York: Barnes & Noble, 1996:85.
14. Eichelbaum M, Spannbrucker N, Steincke B, et al. Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur J Clin Pharmacol 1979;16:183-187.
15. Bathum L, Johansson I, Ingelman-Sundberg M, Horder M, Brosen K. Ultrarapid metabolism of sparteine: Frequency of alleles with duplicated CYP 2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction. Pharmacogenetics 1998;8:119-123.
16. Islam, Science, Environment, and Technology. Online document at: www.islamset.com/sc/plants/ajmaline.html Accessed March 30, 2003.
17. Obayashi K, Nagasawa K, Mandel WJ, et al. Cardiovascular effects of ajmaline. Am Heart J 1976;92:487-496.
18. Kel'man IM, Paleev NR. Prevention of supraventricular tachysystole with anti-arrhythmia agents [in Russian]. Kardiologiia 1977;17:42-45.
19. Yarnell E, Abascal A. Treating hypertension botanically. Altern Complement Ther 2001;7:284-290.
20. Meixner HK, Dobler S. Oral heart therapy using convallaria glycosides in ambulatory practice [in German]. Z Allgemeinmed 1974;50(16):757-768.
21. Weiss RF. Herbal Medicine. Beaconsfield, UK: Beaconsfield Publishers, 1988:146.
22. Lehmann HD. Effect of plant glycosides on resistance and capacitance vessels [in German]. Arzneim Forsch 1984;34:423-429.
23. Kopp B, Loffelhardt W. Determination of progesterone in vegetative organs and cell organelles of Convallaria majalis L. by radioimmunoassay. Z Naturforsch [C] 1980;35:41-44.
24. Garjani A, Nazemiyeh H, Maleki N, Valizadeh H. Effects of extracts from flowering tops of Crataegus meyeri A. Pojark on ischaemic arrhythmias in anaesthetized rats. Phytother Res 2000;14:428-431.
25. Rothfuss MA, Pascht U, Kissling G. Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats. Arzneim Forsch 2001;51:24-28.
26. al Makdessi S, Sweidan H, Dietz K, Jacob R. Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart. Basic Res Cardiol 1999;94:71-77.
27. Schmidt U, Albrecht M, Podzuweit H, et al. High dosage therapy with Crataegus extract in patients suffering from heart failure NYHA class I and II [in German]. Z Phytother 1998;19:22-30.
28. Tauchert M, Gildor A, Lipinski J. High-dose Crataegus (hawthorn) extract WS 1442 for the treatment of NYHA class II heart failure patients [in German]. Herz 1999;24:465-474.